JP Patent

JP6585261B2 — 置換ベンズアルデヒド化合物および組織酸素化の増加におけるそれらの使用方法

Assigned to グローバル ブラッド セラピューティクス インコーポレイテッド · Expires 2019-10-02 · 7y expired

What this patent protects

Patent listed against Oxbryta.

Drugs covered by this patent

Patent Metadata

Patent number
JP6585261B2
Jurisdiction
JP
Classification
—
Expires
2019-10-02
Drug substance claim
No
Drug product claim
No
Assignee
グローバル ブラッド セラピューティクス インコーポレイテッド
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.